BRIEF published on 11/17/2025 at 15:44, 3 months 4 days ago UBS Group AG réduit sa participation dans Worldline Franchissement De Seuil Convertible Bonds Worldline UBS Group AG Actions Et Droits De Vote
BRIEF published on 11/17/2025 at 15:44, 3 months 4 days ago UBS Group AG reduces its stake in Worldline Convertible Bonds Threshold Crossing Shares And Voting Rights Worldline UBS Group AG
BRIEF published on 11/17/2025 at 15:43, 3 months 4 days ago Franchissement de seuil par The Goldman Sachs Group dans VALEO Franchissement De Seuil Actions Goldman Sachs Valeo Options Et Warrants
BRIEF published on 11/17/2025 at 15:43, 3 months 4 days ago The Goldman Sachs Group crosses a threshold in VALEO Actions Goldman Sachs Threshold Crossing Valeo Options And Warrants
BRIEF published on 11/17/2025 at 15:42, 3 months 4 days ago Gold Terra Upsizes Private Placement amid Strong Investor Demand Private Placement Exploration Expenses Investor Demand Gold Terra Yellowknife Project
BRIEF published on 11/17/2025 at 15:42, 3 months 4 days ago Gold Terra augmente le montant de son placement privé face à une forte demande des investisseurs Placement Privé Demande Des Investisseurs Gold Terra Frais D'exploration Projet Yellowknife
BRIEF published on 11/17/2025 at 15:31, 3 months 4 days ago The Goldman Sachs Group réduit sa participation dans NANOBIOTIX Actions Goldman Sachs NANOBIOTIX 5 % Seuil Prêt De Titre
BRIEF published on 11/17/2025 at 15:31, 3 months 4 days ago The Goldman Sachs Group reduces its stake in NANOBIOTIX Actions Goldman Sachs NANOBIOTIX 5% Threshold Title Loan
BRIEF published on 11/17/2025 at 15:24, 3 months 4 days ago First Berlin Equity Research Reaffirms BUY Rating for Lisata Therapeutics BUY Rating Research Update Strategic Collaborations Lisata Therapeutics Certepetide Platform
BRIEF published on 11/17/2025 at 15:24, 3 months 4 days ago First Berlin Equity Research réaffirme sa recommandation d'achat sur Lisata Therapeutics Mise À Jour De La Recherche Collaborations Stratégiques Évaluation D'achat Lisata Thérapeutique Plateforme Certepetide
Published on 02/21/2026 at 00:45, 18 hours 38 minutes ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 18 hours 53 minutes ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 20 hours 23 minutes ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 21 hours 6 minutes ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/21/2026 at 12:00, 7 hours 23 minutes ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 7 hours 23 minutes ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 19:29, 23 hours 53 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 23 hours 53 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
